Cargando…
Cryptococcosis complicating diabetes mellitus: a scoping review
BACKGROUND: A better understanding of the epidemiology of cryptococcal infection in HIV-negative individuals is an international research interest. Immune dysfunction in diabetes mellitus (DM) significantly increases the risk of acquiring and reactivation of infection due to Cryptococcus neoformans....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111545/ https://www.ncbi.nlm.nih.gov/pubmed/33996076 http://dx.doi.org/10.1177/20499361211014769 |
_version_ | 1783690523866824704 |
---|---|
author | Nsenga, Lauryn Kajjimu, Jonathan Olum, Ronald Ninsiima, Sandra Kyazze, Andrew Peter Ssekamatte, Phillip Kibirige, Davis Baluku, Joseph Baruch Andia-Biraro, Irene Bongomin, Felix |
author_facet | Nsenga, Lauryn Kajjimu, Jonathan Olum, Ronald Ninsiima, Sandra Kyazze, Andrew Peter Ssekamatte, Phillip Kibirige, Davis Baluku, Joseph Baruch Andia-Biraro, Irene Bongomin, Felix |
author_sort | Nsenga, Lauryn |
collection | PubMed |
description | BACKGROUND: A better understanding of the epidemiology of cryptococcal infection in HIV-negative individuals is an international research interest. Immune dysfunction in diabetes mellitus (DM) significantly increases the risk of acquiring and reactivation of infection due to Cryptococcus neoformans. Risk factors and outcomes of cryptococcosis in DM are not well documented. OBJECTIVE: The objective of this study was to determine the clinical characteristics and outcomes of cryptococcal infections in persons living with DM. METHODS: MEDLINE (via PubMed), EMBASE, and the Cochrane Library databases were searched in November 2020. The searches covered the period between 1980 and 2020.We included studies that reported confirmed cryptococcosis in patients with DM. Reference lists of included articles were also searched, and additional studies were included if appropriate. No language restriction was applied. Single case reports, case series and original articles were included whereas review articles were excluded. RESULTS: A total of 28 studies (24 single case reports, 4 retrospectives) were included involving 47 unique patients from Asia (17 cases), North America (six cases), South America (three cases) and Africa (two cases). Men constituted 75% (n = 18) of the cases. Median age was 60.5 (range: 27–79) years. The majority of the patients had cryptococcal meningitis (68.1%, n = 32) followed by disseminated cryptococcosis (6.4%, n = 7), and others (isolated cutaneous disease one, peritonitis one, pleural one, thyroid one, adrenal one). Diagnosis was achieved through either culture and microscopy (38/47), cryptococcal antigen tests (9/47) or histopathology (9/47) singly or in a combination. All-cause mortality was 38.3% (n = 18). Among those with meningitis mortality was 36.2%. CONCLUSION: A wide spectrum of cryptococcal infections with varying severity occurs in DM. Mortality remains unacceptably high. There is a need for more studies to characterize better cryptococcal disease in DM. |
format | Online Article Text |
id | pubmed-8111545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-81115452021-05-14 Cryptococcosis complicating diabetes mellitus: a scoping review Nsenga, Lauryn Kajjimu, Jonathan Olum, Ronald Ninsiima, Sandra Kyazze, Andrew Peter Ssekamatte, Phillip Kibirige, Davis Baluku, Joseph Baruch Andia-Biraro, Irene Bongomin, Felix Ther Adv Infect Dis Review BACKGROUND: A better understanding of the epidemiology of cryptococcal infection in HIV-negative individuals is an international research interest. Immune dysfunction in diabetes mellitus (DM) significantly increases the risk of acquiring and reactivation of infection due to Cryptococcus neoformans. Risk factors and outcomes of cryptococcosis in DM are not well documented. OBJECTIVE: The objective of this study was to determine the clinical characteristics and outcomes of cryptococcal infections in persons living with DM. METHODS: MEDLINE (via PubMed), EMBASE, and the Cochrane Library databases were searched in November 2020. The searches covered the period between 1980 and 2020.We included studies that reported confirmed cryptococcosis in patients with DM. Reference lists of included articles were also searched, and additional studies were included if appropriate. No language restriction was applied. Single case reports, case series and original articles were included whereas review articles were excluded. RESULTS: A total of 28 studies (24 single case reports, 4 retrospectives) were included involving 47 unique patients from Asia (17 cases), North America (six cases), South America (three cases) and Africa (two cases). Men constituted 75% (n = 18) of the cases. Median age was 60.5 (range: 27–79) years. The majority of the patients had cryptococcal meningitis (68.1%, n = 32) followed by disseminated cryptococcosis (6.4%, n = 7), and others (isolated cutaneous disease one, peritonitis one, pleural one, thyroid one, adrenal one). Diagnosis was achieved through either culture and microscopy (38/47), cryptococcal antigen tests (9/47) or histopathology (9/47) singly or in a combination. All-cause mortality was 38.3% (n = 18). Among those with meningitis mortality was 36.2%. CONCLUSION: A wide spectrum of cryptococcal infections with varying severity occurs in DM. Mortality remains unacceptably high. There is a need for more studies to characterize better cryptococcal disease in DM. SAGE Publications 2021-05-05 /pmc/articles/PMC8111545/ /pubmed/33996076 http://dx.doi.org/10.1177/20499361211014769 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Review Nsenga, Lauryn Kajjimu, Jonathan Olum, Ronald Ninsiima, Sandra Kyazze, Andrew Peter Ssekamatte, Phillip Kibirige, Davis Baluku, Joseph Baruch Andia-Biraro, Irene Bongomin, Felix Cryptococcosis complicating diabetes mellitus: a scoping review |
title | Cryptococcosis complicating diabetes mellitus: a scoping review |
title_full | Cryptococcosis complicating diabetes mellitus: a scoping review |
title_fullStr | Cryptococcosis complicating diabetes mellitus: a scoping review |
title_full_unstemmed | Cryptococcosis complicating diabetes mellitus: a scoping review |
title_short | Cryptococcosis complicating diabetes mellitus: a scoping review |
title_sort | cryptococcosis complicating diabetes mellitus: a scoping review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111545/ https://www.ncbi.nlm.nih.gov/pubmed/33996076 http://dx.doi.org/10.1177/20499361211014769 |
work_keys_str_mv | AT nsengalauryn cryptococcosiscomplicatingdiabetesmellitusascopingreview AT kajjimujonathan cryptococcosiscomplicatingdiabetesmellitusascopingreview AT olumronald cryptococcosiscomplicatingdiabetesmellitusascopingreview AT ninsiimasandra cryptococcosiscomplicatingdiabetesmellitusascopingreview AT kyazzeandrewpeter cryptococcosiscomplicatingdiabetesmellitusascopingreview AT ssekamattephillip cryptococcosiscomplicatingdiabetesmellitusascopingreview AT kibirigedavis cryptococcosiscomplicatingdiabetesmellitusascopingreview AT balukujosephbaruch cryptococcosiscomplicatingdiabetesmellitusascopingreview AT andiabiraroirene cryptococcosiscomplicatingdiabetesmellitusascopingreview AT bongominfelix cryptococcosiscomplicatingdiabetesmellitusascopingreview |